Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Anthem Biosciences Limited

Meeting Details

  • Date: Wednesday, July 22, 2026
  • Time: 03:30 PM IST
  • Location: Conducted through Video Conferencing (VC)/Other Audio-Visual Means (OAVM)
  • Type: 20th Annual General Meeting
  • Deemed Venue: Registered Office of the Company
  • Participation Link: https://emeetings.kfintech.com

Proposed Resolutions and Implications

Ordinary Business:

1. Adoption of Financial Statements: To consider and adopt the audited financial statements (including consolidated financial statements) for the financial year ended March 31, 2026, along with reports of the Board of Directors and Auditors.

2. Declaration of Dividend: To declare a final dividend of ₹2.00 per equity share (face value ₹2.00 each) for FY 2025-26, subject to shareholder approval. The dividend will be paid to members registered as beneficial owners as of the record date Friday, June 26, 2026.

3. Reappointment of Director: To reappoint Mr. K Ravindra Chandrappa (DIN: 01580534) as a Director who retires by rotation.

4. Appointment of Statutory Auditors: To appoint M/s. S.R. Batliboi & Associates LLP, Chartered Accountants (FRN 101049W/E300004) as statutory auditors for a term of five years commencing from the conclusion of this AGM until the conclusion of the AGM in FY 2031-32, at a remuneration of ₹63,50,000 for FY 2026-27, excluding applicable taxes and out-of-pocket expenses.

Special Business:

5. Continuation of Independent Director: Special resolution to approve the continuation of Mr. Ravikant Uppal (DIN: 00025970) as Non-Executive Independent Director upon attaining the age of 75 years for the remainder of his term ending September 26, 2029.

6. Commission to Independent Directors: To approve payment of commission to Non-Executive Independent Directors, not exceeding 1% of the net profits of the Company computed under Section 198 of the Companies Act, 2013.

7. Remuneration to Related Parties: To approve increased remuneration to related parties holding office or place of profit:

  • Mr. Ishaan Bhardwaj (Vice President, Promoter): ₹15.00 million
  • Ms. Krithika Ganesh (Deputy Manager, Promoter Group): ₹3.75 million
  • Ms. Keerthana Ravindra (Deputy Manager, Promoter Group): ₹3.35 million

8. Upside Sharing Arrangement: To approve the upside sharing arrangement with Viridity Tone LLP, where gains realized by the investor from divestment exceeding agreed thresholds (higher of 25% IRR or 2x investment) will be shared with promoters Dr. Ajay Bhardwaj, Dr. Ganesh Sambasivam, and Mr. K Ravindra Chandrappa. The investor has realized approximately ₹13,170 million from divestments, triggering an upside sharing amount of approximately ₹1,276.83 million.

Voting Process and Methods

  • Voting Methods: Remote e-voting and e-voting during the AGM
  • Cut-off Date for E-voting: Friday, July 17, 2026
  • Remote E-voting Period: Sunday, July 19, 2026 (9:00 AM IST) to Tuesday, July 21, 2026 (5:00 PM IST)
  • E-voting During AGM: Integrated with VC platform for members who haven't voted remotely
  • Scrutinizer: CS Pramod S M (Membership No. F7834) or in his absence CS Biswajit Ghosh (Membership No. F8750) of M/s. BMP & Co. LLP
  • Result Declaration: Scrutinizer's report to be submitted within 48 hours of AGM conclusion, with results communicated to stock exchanges and displayed on company website

Dividend Information

  • Record Date: Friday, June 26, 2026
  • Payment Date: On or before Friday, August 21, 2026
  • Dividend Amount: ₹2.00 per equity share
  • Tax Deduction: TDS applicable as per Income Tax Act provisions
  • Resident individuals: 10% with valid PAN, 20% without valid PAN
  • No TDS if dividend amount ≤ ₹10,000 annually
  • Non-resident shareholders: 20% plus applicable surcharge and cess
  • DTAA benefits available subject to documentation
  • Submission Deadline for Tax Documents: Wednesday, July 15, 2026

Compliance and Regulatory References

  • Conducted in compliance with MCA General Circular No. 3/2025 and SEBI circulars regarding virtual meetings
  • Notice sent electronically to members with registered email addresses
  • Physical attendance dispensed with; proxy facility not available
  • Quorum requirements under Section 103 of Companies Act, 2013 to be met through VC/OAVM attendance
  • All resolutions comply with Companies Act, 2013 and SEBI LODR Regulations

Additional Information

  • The company has three manufacturing units: Unit I (Bommasandra), Unit II (Harohalli), and Unit III (Neoanthem @ Harohalli)
  • Register of Directors and Key Managerial Personnel available for inspection
  • Institutional shareholders required to submit authorization documents by July 21, 2026
  • Members can request hard copies of annual report by email to investors.abl@anthembio.com
  • The notice and annual report are available on company website and stock exchange websites